KYTX SCHEDULE 13G/A: SEC filing
A Schedule 13G/A amendment was
Filed with the SEC on · accession 0001193125-26-350332
KYTX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. A Schedule 13G/A amendment was filed regarding beneficial ownership of Kyverna Therapeutics (KYTX) common stock. The stock moved +1.1% by the first close after the filing.
Summary of the filing
A Schedule 13G/A amendment was filed regarding beneficial ownership of Kyverna Therapeutics (KYTX) common stock. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
Key details
How KYTX stock reacted
Close before
$8.08
Aug 13, 2026
First close after
+1.11%
$8.17
5 trading days
+0.62%
$8.13
Since filing
-39.60%
$4.88
✦ Ask GOAX AI about this filing — what it means for KYTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for KYTX?
Click hereFrequently asked questions
What did KYTX file with the SEC on Aug 14, 2026?
KYTX filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding beneficial ownership of Kyverna Therapeutics (KYTX) common stock. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did KYTX stock react to this filing?
KYTX closed at $8.08 before the filing and $8.17 on Aug 14, 2026 (+1.11%). Five trading days later: $8.13 (+0.62%).
Other KYTX SEC filings
- SCHEDULE 13G · SEC filingOct 19, 2026
- 8-K · Fda approvalSep 24, 2026
- 10-Q · SEC filingAug 11, 2026
- 8-K · SEC filingAug 11, 2026
- 8-K · Material agreementJul 27, 2026
- 8-K · Material agreementJul 9, 2026
- 8-K · Board changeJun 2, 2026
- 8-K · Cfo changeMay 18, 2026
- 10-Q · SEC filingMay 12, 2026
- 8-K · SEC filingMay 12, 2026
Get alerts when KYTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days